Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease

Erythropoiesis-stimulating agents (ESAs) are effective in ameliorating anemia in chronic kidney disease (CKD). However, a recent trial in diabetic CKD patients suggested a greater stroke risk associated with full correction of anemia using ESAs. We performed a case-control study examining the associ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Seliger, Stephen L., Zhang, Amy D., Weir, Matthew R., Walker, Loreen, Hsu, Van Doren, Parsa, Afshin, Diamantidis, Clarissa, Fink, Jeffrey C.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882072/
https://ncbi.nlm.nih.gov/pubmed/21389972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2011.49
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars